Cortisone Acetate has 5 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Somatropin, Lonapegsomatropin-Tcgd, Somapacitan-Beco. Patients taking Cortisone Acetate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Major
- 1
- Moderate
- 4
Major (1)
- Cortisone Acetate + Somatropin— Somatropin inhibits conversion of cortisone acetate to its active metabolite cortisol. Patients may require increased ma…
Moderate (4)
- Cortisone Acetate + Lonapegsomatropin-Tcgd— SKYTROFA inhibits 11βHSD-1, reducing conversion of cortisone to active cortisol. Patients on glucocorticoid replacement …
- Cortisone Acetate + Somapacitan-Beco— SOGROYA may inhibit 11βHSD-1 and reduce serum cortisol concentrations, potentially requiring increased glucocorticoid ma…
- Cortisone Acetate + Somatrogon-Ghla— NGENLA may inhibit 11βHSD-1 and reduce serum cortisol concentrations. Patients on cortisone acetate replacement for hypo…
- Cortisone Acetate + Tesamorelin— May require dose adjustment as conversion to active metabolite is dependent on 11βHSD-1 activity, which is inhibited by …